First Online: 1 October 2020
: C.L. is funded by a UKRI Future Leaders Fellowship and has received additional research support from AbbVie, Chief Scientist’s Office, Cure Crohn’s Colitis and Gilead. He has received consultancy fees from AbbVie, Dr Falk, Gilead, Hospira, Iterative Scopes, Janssen, Oshi Health, Pfizer, Takeda, Trellus Health and Vifor Pharma. He has received speaking fees and travel support from AbbVie, Dr. Falk, Ferring, Gilead, Hospira, Janssen, Pfizer and Takeda.